Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders

Insiders Menu
Roster
Transactions
FATE THERAPEUTICS INC (FATE)

DateNameTitleTypeSecuritySharesPriceValueOwnershipReported
08/18/2023Dulac Edward J IIICFOSaleCommon Stock4.7k$2.80$13.2k 08/18/2023
08/04/2023Xu YuanDirectorSaleCommon Stock632$3.71$2.3k 08/04/2023
07/05/2023Powl Brian T.Chief Commercial OfficerSaleCommon Stock3.9k$4.87$18.8k 07/05/2023
07/05/2023Dulac Edward J IIICFOSaleCommon Stock5.2k$4.83$25k 07/05/2023
06/06/2023Jooss KarinDirectorGrantStock Option (Right to Buy)40k$5.52$220.8k 06/06/2023
06/06/2023Xu YuanDirectorGrantStock Option (Right to Buy)40k$5.52$220.8k 06/06/2023
06/06/2023Redmile Group, LLC10% OwnerGrantStock Option (Right to Buy)40k$5.52$220.8kSee Footnote06/06/2023
06/06/2023HERSHBERG ROBERTDirectorGrantStock Option (Right to Buy)40k$5.52$220.8k 06/06/2023
06/06/2023COUGHLIN TIMOTHYDirectorGrantStock Option (Right to Buy)40k$5.52$220.8k 06/06/2023
06/06/2023MENDLEIN JOHNDirectorGrantStock Option (Right to Buy)40k$5.52$220.8k 06/06/2023
06/06/2023EPSTEIN ROBERT SDirectorGrantStock Option (Right to Buy)40k$5.52$220.8k 06/06/2023
06/06/2023RASTETTER WILLIAM HDirectorGrantStock Option (Right to Buy)40k$5.52$220.8k 06/06/2023
06/06/2023Agarwal ShefaliDirectorGrantStock Option (Right to Buy)40k$5.52$220.8k 06/06/2023
06/06/2023Lee Michael StewartDirectorGrantStock Option (Right to Buy)40k$5.52$220.8k 06/06/2023
02/06/2023Valamehr BahramChief R&D OfficerGrantStock Option (Right to Buy)450k$6.77$3M 02/06/2023
02/06/2023Dulac Edward J IIICFOGrantStock Option (Right to Buy)425k$6.77$2.9M 02/06/2023
02/06/2023TAHL CINDYGeneral Counsel and SecretaryGrantStock Option (Right to Buy)425k$6.77$2.9M 02/06/2023
02/06/2023Wolchko J ScottPresident and CEOGrantStock Option (Right to Buy)500k$6.77$3.4M 02/06/2023
02/06/2023Powl Brian T.Chief Commercial OfficerGrantStock Option (Right to Buy)425k$6.77$2.9M 02/06/2023
02/06/2023Chu Yu-WayeChief Medical OfficerGrantStock Option (Right to Buy)425k$6.77$2.9M 02/06/2023
01/19/2023MENDLEIN JOHNDirectorExerciseStock Option (Right to Buy)28.5k$1.37$39k 01/19/2023
01/13/2023MENDLEIN JOHNDirectorPurchaseCommon Stock36.6k$5.43$198.9k 01/11/2023
01/12/2023Valamehr BahramChief R&D OfficerExerciseStock Option (Right to Buy)423$1.37$579.5 01/12/2023
01/11/2023MENDLEIN JOHNDirectorPurchaseCommon Stock88k$5.67$499.2k 01/11/2023
01/10/2023Wolchko J ScottPresident and CEOSaleCommon Stock45.9k$5.24$240.6k 01/10/2023
01/10/2023Valamehr BahramChief R&D OfficerSaleCommon Stock10.9k$5.24$57.2k 01/10/2023
01/10/2023TAHL CINDYGeneral Counsel and SecretarySaleCommon Stock11.6k$5.24$60.5k 01/10/2023
01/10/2023Chu Yu-WayeChief Medical OfficerSaleCommon Stock7.8k$5.24$41k 01/10/2023
01/10/2023Dulac Edward J IIICFOSaleCommon Stock7.3k$5.24$38.4k 01/10/2023
01/10/2023Plavsic MarkChief Technical OfficerSaleCommon Stock3.4k$5.24$17.9k 01/10/2023
08/18/2022Dulac Edward J IIICFOSaleCommon Stock4.7k$29.75$139.9k 08/18/2022
08/18/2022Dulac Edward J IIICFOSaleCommon Stock432$30.41$13.1k 08/18/2022
07/22/2022Wolchko J ScottPresident and CEOSaleCommon Stock2.9k$31.33$91.6k 07/21/2022
07/22/2022Wolchko J ScottPresident and CEOSaleCommon Stock2.7k$32.61$88.1k 07/21/2022
07/22/2022Wolchko J ScottPresident and CEOSaleCommon Stock620$33.28$20.6k 07/21/2022
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy